APYX   $3.9472  13.43% Market Open

Apyx Medical Corporation
Total Cash 32.68M
totalCashPerShare 0.943
EBITDA -21.67M
Total Debt 38.70M
quickRatio 4.266
currentRatio 5.327
Total Revenue 49.03M
debtToEquity 259.321
Revenue/Share 1.415
ROA -0.21832001
ROE -1.10246
grossProfits
freeCashflow 3.78M
operatingCashflow -9.19M
earningsGrowth
revenueGrowth -0.105
grossMargins 0.61898
ebitdaMargins -0.44205
operatingMargins -0.45658
profitMargins -0.57857
enterpriseValue 46.73M
forwardPE -1.8134328
floatShares 25.92M
sharesOutstanding 34.64M
sharesShort 234.86K
sharesShortPriorMonth 243.91K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.16%
heldPercentInstitutions 0.40%
Short Ratio help_outline 5.49%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 0.426
Price To Book help_outline 2.85
earningsQuarterlyGrowth
netIncomeToCommon -28.37M
trailingEps -0.82%
forwardEps -0.67%
enterpriseToEbitda -2.16
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.19 3Q 2024
institutionsCount 61
lastUpdated Nov. 6, 2024, 6:22 p.m.